272 related articles for article (PubMed ID: 23593301)
1. Use of a bacteriophage lysin to identify a novel target for antimicrobial development.
Schuch R; Pelzek AJ; Raz A; Euler CW; Ryan PA; Winer BY; Farnsworth A; Bhaskaran SS; Stebbins CE; Xu Y; Clifford A; Bearss DJ; Vankayalapati H; Goldberg AR; Fischetti VA
PLoS One; 2013; 8(4):e60754. PubMed ID: 23593301
[TBL] [Abstract][Full Text] [Related]
2. The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against
Schuch R; Pelzek AJ; Nelson DC; Fischetti VA
Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30850428
[TBL] [Abstract][Full Text] [Related]
3. A genetic screen to identify bacteriophage lysins.
Schuch R; Fischetti VA; Nelson DC
Methods Mol Biol; 2009; 502():307-19. PubMed ID: 19082564
[TBL] [Abstract][Full Text] [Related]
4. The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.
Ganguly J; Low LY; Kamal N; Saile E; Forsberg LS; Gutierrez-Sanchez G; Hoffmaster AR; Liddington R; Quinn CP; Carlson RW; Kannenberg EL
Glycobiology; 2013 Jul; 23(7):820-32. PubMed ID: 23493680
[TBL] [Abstract][Full Text] [Related]
5. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis.
Porter CJ; Schuch R; Pelzek AJ; Buckle AM; McGowan S; Wilce MC; Rossjohn J; Russell R; Nelson D; Fischetti VA; Whisstock JC
J Mol Biol; 2007 Feb; 366(2):540-50. PubMed ID: 17182056
[TBL] [Abstract][Full Text] [Related]
6. Gamma-phage lysin PlyG sequence-based synthetic peptides coupled with Qdot-nanocrystals are useful for developing detection methods for Bacillus anthracis by using its surrogates, B. anthracis-Sterne and B. cereus-4342.
Sainathrao S; Mohan KV; Atreya C
BMC Biotechnol; 2009 Jul; 9():67. PubMed ID: 19624851
[TBL] [Abstract][Full Text] [Related]
7. A bacteriolytic agent that detects and kills Bacillus anthracis.
Schuch R; Nelson D; Fischetti VA
Nature; 2002 Aug; 418(6900):884-9. PubMed ID: 12192412
[TBL] [Abstract][Full Text] [Related]
8. New bacteriophage-derived lysins, LysJ and LysF, with the potential to control Bacillus anthracis.
Nakonieczna A; Topolska-Woś A; Łobocka M
Appl Microbiol Biotechnol; 2024 Dec; 108(1):76. PubMed ID: 38194144
[TBL] [Abstract][Full Text] [Related]
9. Existence of separate domains in lysin PlyG for recognizing Bacillus anthracis spores and vegetative cells.
Yang H; Wang DB; Dong Q; Zhang Z; Cui Z; Deng J; Yu J; Zhang XE; Wei H
Antimicrob Agents Chemother; 2012 Oct; 56(10):5031-9. PubMed ID: 22802245
[TBL] [Abstract][Full Text] [Related]
10. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
Heselpoth RD; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis.
Kikkawa HS; Ueda T; Suzuki S; Yasuda J
FEMS Microbiol Lett; 2008 Sep; 286(2):236-40. PubMed ID: 18662316
[TBL] [Abstract][Full Text] [Related]
12. Identification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of gamma-phage, PlyG, to Bacillus anthracis.
Kikkawa H; Fujinami Y; Suzuki S; Yasuda J
Biochem Biophys Res Commun; 2007 Nov; 363(3):531-5. PubMed ID: 17888883
[TBL] [Abstract][Full Text] [Related]
13. Communication of γ phage lysin plyG enzymes binding toward SrtA for inhibition of Bacillus anthracis: protein-protein interaction and molecular dynamics study.
Selvaraj C; Bharathi Priya R; Singh SK
Cell Commun Adhes; 2014 Oct; 21(5):257-65. PubMed ID: 24978154
[TBL] [Abstract][Full Text] [Related]
14. Binding domains of Bacillus anthracis phage endolysins recognize cell culture age-related features on the bacterial surface.
Paskaleva EE; Mundra RV; Mehta KK; Pangule RC; Wu X; Glatfelter WS; Chen Z; Dordick JS; Kane RS
Biotechnol Prog; 2015; 31(6):1487-93. PubMed ID: 26399565
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.
Fischetti VA
Int J Med Microbiol; 2010 Aug; 300(6):357-62. PubMed ID: 20452280
[TBL] [Abstract][Full Text] [Related]
16. A Novel
Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
mSphere; 2017; 2(2):. PubMed ID: 28357414
[TBL] [Abstract][Full Text] [Related]
17. Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.
Panchal RG; Geller BL; Mellbye B; Lane D; Iversen PL; Bavari S
Nucleic Acid Ther; 2012 Oct; 22(5):316-22. PubMed ID: 22978365
[TBL] [Abstract][Full Text] [Related]
18. Identification of Bacillus anthracis PurE inhibitors with antimicrobial activity.
Kim A; Wolf NM; Zhu T; Johnson ME; Deng J; Cook JL; Fung LW
Bioorg Med Chem; 2015 Apr; 23(7):1492-9. PubMed ID: 25737087
[TBL] [Abstract][Full Text] [Related]
19. Production and application of bacteriophage and bacteriophage-encoded lysins.
Courchesne NM; Parisien A; Lan CQ
Recent Pat Biotechnol; 2009; 3(1):37-45. PubMed ID: 19149721
[TBL] [Abstract][Full Text] [Related]
20. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.
Fischetti VA
Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
